+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID04119713

Understanding Immune-Related Side Effects in Cancer Patients Treated with Checkpoint Inhibitors

Led by Abramson Cancer Center at Penn Medicine · Updated on 2026-10-05

600

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying how cancer treatment with immune checkpoint inhibitors ICI can lead to the development of autoimmunity in some patients. The study focuses on understanding the genetic and immune system factors that cause certain cancer patients receiving checkpoint inhibitor therapy to experience immune-related adverse events irAEs. This observational study aims to enroll at least 300 adult cancer patients prescribed checkpoint inhibitors to gather detailed clinical and biological information. Participants will provide peripheral blood and serum samples at enrollment and at specific times during their treatment, such as when receiving therapeutic infusions, routine clinical lab visits, and if they develop autoimmune symptoms. Urine samples may also be collected during these times. There is no treatment or intervention in this study instead, clinical data is collected from medical records and biological samples to analyze immune cell types and functions. During the study, participants will be monitored through blood and urine sample collections and clinical data extraction over up to six years. Researchers will examine the characteristics of immune cells, the occurrence of immune-related adverse events, and the impact of these findings on future research collaborations. All data is securely stored to protect participant privacy. The study involves no additional treatment and focuses on observation and sample collection.

CONDITIONS

Brief Title

Autoimmunity After Checkpoint Blockade

Research Team

K

Kyra J Sacksith

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here